These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8801835)
1. [Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia]. Triki H Arch Inst Pasteur Tunis; 1994; 71(3-4):403-6. PubMed ID: 8801835 [No Abstract] [Full Text] [Related]
2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [TBL] [Abstract][Full Text] [Related]
3. [HBV and HCV coinfections in children--own investigations]. Pawłowska M; Halota W Przegl Epidemiol; 2003; 57(3):459-64. PubMed ID: 14682164 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and C in Egypt and Africa. Attia MA Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia. Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755 [TBL] [Abstract][Full Text] [Related]
6. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C virus and chronic hepatopathies in Dakar: case-control study]. Mbaye PS; Renaudineau Y; Diallo A; Haudrechy D; Sane M; Michel G; Raphenon G; Klotz F Med Trop (Mars); 2000; 60(1):47-52. PubMed ID: 10989787 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. Mumtaz K; Hamid SS; Adil S; Afaq A; Islam M; Abid S; Shah HA; Jafri W J Gastroenterol Hepatol; 2005 Oct; 20(10):1503-7. PubMed ID: 16174065 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and etiologic features of hepatocarcinoma in Sicily]. Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Viana S; Paraná R; Moreira RC; Compri AP; Macedo V Am J Trop Med Hyg; 2005 Oct; 73(4):808-14. PubMed ID: 16222030 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981 [TBL] [Abstract][Full Text] [Related]
12. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Yuen MF; Sablon E; Yuan HJ; Wong DK; Hui CK; Wong BC; Chan AO; Lai CL Hepatology; 2003 Mar; 37(3):562-7. PubMed ID: 12601354 [TBL] [Abstract][Full Text] [Related]
13. [Etiology of hepatocellular carcinomas in Madagascar: results of a study in Antananarivo from October 1995 to October 1996]. Zeller HG; Rakotonirina J; Morel B; Pécarrère JL; Lapprand M Arch Inst Pasteur Madagascar; 1996; 63(1-2):62-6. PubMed ID: 12463021 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745 [TBL] [Abstract][Full Text] [Related]
15. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study]. Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063 [TBL] [Abstract][Full Text] [Related]
16. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [TBL] [Abstract][Full Text] [Related]
17. [Antibodies against viral hepatitis C in groups at risk]. Roşiu N; Pop O; Claici C; Cioflec D; Novac VP; Strein R; Nicoară E; Bodea A; Boieriu E; Niculescu V Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):84-7. PubMed ID: 7981534 [No Abstract] [Full Text] [Related]
18. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327 [TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. Ikeda K; Kobayashi M; Someya T; Saitoh S; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H J Viral Hepat; 2009 Jun; 16(6):437-43. PubMed ID: 19226331 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]